Literature DB >> 10637510

Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

S Yoshida1, Y Kaneita, Y Aoki, M Seto, S Mori, M Moriyama.   

Abstract

In order to elucidate the molecular mechanism(s) for BCL6 translocation, we identified translocational partner genes by subjecting clinical biopsy samples from patients with non-Hodgkin's lymphoma to 5'-rapid amplification of cDNA ends (5'-RACE). Sequence analysis of the 5'-RACE product revealed that the BCL6 gene was fused to the J segment of the immunoglobulin heavy chain (IgH) gene in about half of the cases, but in the other half, it was fused to heterologous partners, including the MHC class II transactivator (CIITA), pim-1, eukaryotic initiation factor 4AII (eif4AII), transferrin receptor (TFRR) and ikaros genes. Since analyses using genomic long and accurate (LA) - PCR revealed that the breakpoints in the partner gene were confined to the first intron or the second exon in all cases, the promoter and the first exon of the BCL6 gene were replaced by the promoter and the first or both the first and second exon of the partner gene. The breakpoint flanking sequences had no recombination signal sequences (RSSs) or chi sequences and were homologous with the switch region only when the BCL6 gene was fused to the IgH gene, suggesting that BCL6 translocation cannot be explained solely by mistakes of V(D)J, or chi-mediated or class-switch recombination, but rather another mechanism may also be required to explain the molecular mechanism for the promiscuous BCL6 translocation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10637510     DOI: 10.1038/sj.onc.1203293

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.

Authors:  Marie Jarosova; Eva Kriegova; Petra Schneiderova; Regina Fillerova; Vit Prochazka; Michaela Mikesova; Patrik Flodr; Karel Indrak; Tomas Papajik
Journal:  Pathol Oncol Res       Date:  2015-08-30       Impact factor: 3.201

2.  Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase.

Authors:  Kevin C Qian; Joey Studts; Lian Wang; Kevin Barringer; Anthony Kronkaitis; Charline Peng; Alistair Baptiste; Roger LaFrance; Sheenah Mische; Bennett Farmer
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-02

Review 3.  Molecular mechanisms of lymphomagenesis through transcriptional disregulation by chromosome translocation.

Authors:  Masao Seto
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

5.  Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells.

Authors:  Zeping Wang; Yandong Zhang; Juan Jenny Gu; Christine Davitt; Raymond Reeves; Nancy S Magnuson
Journal:  Int J Biochem Cell Biol       Date:  2010-03-20       Impact factor: 5.085

6.  A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas.

Authors:  María-Jesús Artiga; Ana-Isabel Sáez; Cristina Romero; Margarita Sánchez-Beato; Mari-Sol Mateo; Concepción Navas; Manuela Mollejo; Miguel A Piris
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.

Authors:  Ying-Wei Lin; Zanna M Beharry; Elizabeth G Hill; Jin H Song; Wenxue Wang; Zuping Xia; Zhenhua Zhang; Peter D Aplan; Jon C Aster; Charles D Smith; Andrew S Kraft
Journal:  Blood       Date:  2009-11-23       Impact factor: 22.113

8.  The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Authors:  Casey J Fox; Peter S Hammerman; Ryan M Cinalli; Stephen R Master; Lewis A Chodosh; Craig B Thompson
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

9.  The PIM-2 kinase is an essential component of the ultraviolet damage response that acts upstream to E2F-1 and ATM.

Authors:  Shahar Zirkin; Ateret Davidovich; Jeremy Don
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

10.  Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma.

Authors:  Carol Hogan; Caroline Hutchison; Lynnette Marcar; Diane Milne; Mark Saville; John Goodlad; Neil Kernohan; David Meek
Journal:  J Biol Chem       Date:  2008-05-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.